MK-801 protects the neonatal brain from hypoxic-ischemic damage-Reference-Cited by-同舟云学术

MK-801 protects the neonatal brain from hypoxic-ischemic damage

Published:1987-08 Issue:3 Volume:140 Page:359-361
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

McDonald John W.,Silverstein Faye S.,Johnston Michael V.

Publisher

Elsevier BV

Subject

Pharmacology

Reference5 articles.

1. Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury;Johnston;Ann. Neurol.,1983

2. Possible therapeutic implications of antagonists of excitatory amino acid neurotransmitters;Meldrum;Clin. Sci.,1985

3. Silverstein, F.S., L. Torke, J. Barks and M.V. Johnston, Hypoxia-ischemia produces focal disruption of glutamine receptors in developing brain, Dev. Br. Res. (in press).

4. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain;Simon;Science,1984

5. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist;Wong,1986

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced Hyperglycemia as a Potential Contributor to Translational Failure of Uncompetitive NMDA Receptor Antagonists;eneuro;2021-11

2. The Function of the NMDA Receptor in Hypoxic-Ischemic Encephalopathy;Frontiers in Neuroscience;2020-10-06

3. Hypothermia but not NMDA receptor antagonism protects against stroke induced by distal middle cerebral arterial occlusion in mice;PLOS ONE;2020-03-03

4. A working model for hypothermic neuroprotection;The Journal of Physiology;2018-05-24

5. Pathophysiology;Volpe's Neurology of the Newborn;2018